Evidence map›Paper›PMID 37189824›Full record

ArticleBiomedicines2023

Angiopoietin-like 2 Protein and Hidradenitis Suppurativa: A New Biomarker for Disease Severity.

José L Hernández, J Gonzalo Ocejo-Vinyals, Mónica Renuncio-García, Elena González-López, Ricardo Blanco, Marcos A González-López

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

José L HernándezInternal Medicine Division, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain.ORCID 0000-0002-6585-8847
J Gonzalo Ocejo-VinyalsValdecilla Research Institute, Valdecilla (IDIVAL), 39011 Santander, Spain.ORCID 0000-0003-2245-4639
Mónica Renuncio-GarcíaImmunology Division, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain.
Elena González-LópezImmunology Division, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain.ORCID 0000-0002-0971-3045
Ricardo BlancoMedicine and Psychiatry Department, Universidad de Cantabria, 39011 Santander, Spain.
Marcos A González-LópezMedicine and Psychiatry Department, Universidad de Cantabria, 39011 Santander, Spain.
Marqués de Valdecilla University Hospital · ESUniversidad de Cantabria · ES

Funding

AbbVie (Spain) This study was funded through an unrestricted grant provided by AbbVie
6 · The paper itself

Abstract

Hidradenitis suppurativa (HS) is a chronic inflammatory disease whose pathogenesis is not fully understood at present. The role of proinflammatory cytokines, several adipokines, retinol-binding protein 4, angiopoietin-2 and other molecules has been previously reported. Angiopoietin-like 2 protein (ANGPTL2) is a glycoprotein belonging to the angiopoietin-like family that may play a pivotal role in the pathogenesis of several chronic inflammatory diseases. To our knowledge, the role of serum ANGPTL2 levels in HS has not been assessed to date. In the current case-control study, we aimed to investigate serum ANGPTL2 levels in HS patients and controls and to assess whether ANGPTL2 levels could be associated with the severity of HS. Ninety-four patients with HS and sixty controls of similar age and sex were included in the study. Demographic, anthropometric, and clinical data, as well as routine laboratory parameters and serum concentrations of ANGPTL2, were assessed in all participants. HS patients had significantly higher serum ANGPTL2 levels than controls after adjusting for confounders. Moreover, ANGPTL2 concentrations positively correlated with disease duration and severity. Our results indicate for the first time that serum ANGPTL2 concentrations are elevated in HS patients compared to controls and correlate with the duration of the disease. Besides, ANGPTL2 might serve as a biomarker of HS severity.

Indexed as

angiopoietin-like 2 proteinhidradenitis suppurativainsulin resistance

Identifiers

PMID37189824
PMCPMC10135524
OpenAlexW4366420622

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.